Kevin E Shopsowitz
Overview
Explore the profile of Kevin E Shopsowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shopsowitz K, Wang X, Soleimani M, Hudoba M, Chen L, McGinnis E
Lancet Oncol
. 2023 Aug;
24(8):e355.
PMID: 37541281
No abstract available.
2.
Biggs C, Cordeiro-Santanach A, Prykhozhij S, Deveau A, Lin Y, Del Bel K, et al.
JCI Insight
. 2022 Dec;
7(24).
PMID: 36546480
Primary atopic disorders are a group of inborn errors of immunity that skew the immune system toward severe allergic disease. Defining the biology underlying these extreme monogenic phenotypes reveals shared...
3.
Shopsowitz K, Tucker T, Bahmanyar M, Farinha P
EJHaem
. 2022 Jul;
2(4):889-890.
PMID: 35845210
No abstract available.
4.
Shopsowitz K, Liu L, Setiadi A, Al-Bakri M, Vercauteren S
Cytometry B Clin Cytom
. 2022 Jun;
102(5):342-352.
PMID: 35726954
Background: Flow cytometry is widely used for B-ALL minimal residual disease (MRD) analysis given its speed, availability, and sensitivity; however, distinguishing B-lymphoblasts from regenerative B-cells is not always straightforward. Radar...
5.
6.
Shopsowitz K, Lim C, Shih A, Fishbane N, Berry B, Bigham M, et al.
Vox Sang
. 2021 Jul;
117(2):251-258.
PMID: 34309031
Background And Objectives: The coronavirus disease 2019 (COVID-19) pandemic raised concerns about the vulnerability of platelet supply and the uncertain impact of the resumption of elective surgery on utilization. We...
7.
Shopsowitz K, Shah K, Tsui H
Cytometry B Clin Cytom
. 2021 Mar;
102(1):73-75.
PMID: 33780164
No abstract available.
8.
9.
Silva A, Shopsowitz K, Correa S, Morton S, Dreaden E, Casimiro T, et al.
Int J Pharm
. 2020 Oct;
591:119989.
PMID: 33122113
Small interfering RNA (siRNA) therapy has significant potential for the treatment of myriad diseases, including cancer. While intravenous routes of delivery have been found to be effective for efficient targeting...
10.
Kong Y, Dreaden E, Morandell S, Zhou W, Dhara S, Sriram G, et al.
Nat Commun
. 2020 Aug;
11(1):4124.
PMID: 32807787
In response to DNA damage, a synthetic lethal relationship exists between the cell cycle checkpoint kinase MK2 and the tumor suppressor p53. Here, we describe the concept of augmented synthetic...